Tempus has announced the expansion of its artificial intelligence platform to include six additional cancer types, enhancing its capabilities for providing clinical insights. This development aims to improve the understanding and treatment of these cancers by leveraging advanced data analytics and machine learning. The expansion is part of Tempus's ongoing commitment to utilizing technology in the fight against cancer, offering healthcare professionals more comprehensive tools for patient care. The specific cancer types included in this expansion have not been disclosed.
Related Articles
Don't miss out on breaking stories and in-depth articles.